Literature DB >> 9778319

Attomole detection of 3H in biological samples using accelerator mass spectrometry: application in low-dose, dual-isotope tracer studies in conjunction with 14C accelerator mass spectrometry.

K H Dingley1, M L Roberts, C A Velsko, K W Turteltaub.   

Abstract

This is the first demonstration of the use of accelerator mass spectrometry (AMS) as a tool for the measurement of 3H with attomole (10(-18) mol) sensitivity in a biological study. AMS is an analytical technique for quantifying rare isotopes with high sensitivity and precision and has been most commonly used to measure 14C in both the geosciences and more recently in biomedical research. AMS measurement of serially diluted samples containing a 3H-labeled tracer showed a strong correlation with liquid scintillation counting. The mean coefficient of variation of 3H AMS based upon the analysis of separately prepared aliquots of these samples was 12%. The sensitivity for 3H detection in tissue, protein, and DNA was approximately 2-4 amol/mg of sample. This high sensitivity is comparable to detection limits for 14C-labeled carcinogens using 14C AMS and demonstrates the feasibility of 3H AMS for biomedical studies. One application of this technique is in low-dose, dual-isotope studies in conjunction with 14C AMS. We measured the levels of 3H-labeled 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 14C-labeled 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in rat liver tissue and bound to liver DNA and protein 4.5 h following acute administration of individual or coadministered doses in the range of 4-5100 pmol/kg of body weight. Levels of PhIP and MeIQx in whole tissue and bound to liver protein were dose-dependent. MeIQx-protein and -DNA adduct levels were higher than PhIP adduct levels, which is consistent with their respective carcinogenicity in this organ. Coadministration of PhIP and MeIQx did not demonstrate any measurable synergistic effects compared to administration of these compounds individually. These studies demonstrate the application of AMS for the low-level detection of 3H in small biological samples and for its use in conjunction with 14C AMS for dual-labeling studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9778319     DOI: 10.1021/tx9801458

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  10 in total

1.  Attomole level protein sequencing by Edman degradation coupled with accelerator mass spectrometry.

Authors:  M Miyashita; J M Presley; B A Buchholz; K S Lam; Y M Lee; J S Vogel; B D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

2.  Use of tritium accelerator mass spectrometry for tree ring analysis.

Authors:  Adam H Love; James R Hunt; Mark L Roberts; John R Southon; Marina L Chiarapp-Zucca; Karen H Dingley
Journal:  Environ Sci Technol       Date:  2002-07-01       Impact factor: 9.028

3.  Isotope-labeled immunoassays without radiation waste.

Authors:  G Shan; W Huang; S J Gee; B A Buchholz; J S Vogel; B D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 4.  From design to the clinic: practical guidelines for translating cardiovascular nanomedicine.

Authors:  Iwona Cicha; Cédric Chauvierre; Isabelle Texier; Claudia Cabella; Josbert M Metselaar; János Szebeni; László Dézsi; Christoph Alexiou; François Rouzet; Gert Storm; Erik Stroes; Donald Bruce; Neil MacRitchie; Pasquale Maffia; Didier Letourneur
Journal:  Cardiovasc Res       Date:  2018-11-01       Impact factor: 10.787

5.  Quantitative metabolism using AMS: Choosing a labeled precursor.

Authors:  Jennifer Links; Magnus Palmblad; Ted Ognibene; Ken Turteltaub; Graham Bench
Journal:  Nucl Instrum Methods Phys Res B       Date:  2010-04-01       Impact factor: 1.377

Review 6.  Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.

Authors:  Robert J Turesky; Loic Le Marchand
Journal:  Chem Res Toxicol       Date:  2011-06-20       Impact factor: 3.739

Review 7.  Salvage of oxidized guanine derivatives in the (2'-deoxy)ribonucleotide pool as source of mutations in DNA.

Authors:  Paul T Henderson; Mark D Evans; Marcus S Cooke
Journal:  Mutat Res       Date:  2010-09-15       Impact factor: 2.433

8.  Human microdosing for the prediction of patient response.

Authors:  Paul T Henderson; Chong-Xian Pan
Journal:  Bioanalysis       Date:  2010-03       Impact factor: 2.681

9.  The vanishing zero revisited: thresholds in the age of genomics.

Authors:  Helmut Zarbl; Michael A Gallo; James Glick; Ka Yee Yeung; Paul Vouros
Journal:  Chem Biol Interact       Date:  2010-01-28       Impact factor: 5.192

10.  Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations.

Authors:  Kate E Coldwell; Suzanne M Cutts; Ted J Ognibene; Paul T Henderson; Don R Phillips
Journal:  Nucleic Acids Res       Date:  2008-07-16       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.